Can AAV continue to deliver the promise of gene therapy? Artwork

The BioInsights Podcast

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

The BioInsights Podcast

Can AAV continue to deliver the promise of gene therapy?

September 13, 2023 • BioInsights • Season 2 • Episode 13

In this episode, Charlotte Barker, Editor, BioInsights, will be discussing the future of AAV-based gene therapy manufacturing with Elie Hanania, VP of Process Development Viral Vector Technologies at Avid Bioservices, and Ratish Krishnan, Senior Strategy Consultant at Merck Life Sciences.